TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Medeca Pharma AB
Closing information (x1000 EUR)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
740
|
674
|
1,746 |
| Financial expenses |
12
|
7
|
1 |
| Earnings before taxes |
-149
|
-88
|
155 |
| EBITDA |
-136
|
-80
|
156 |
| Total assets |
690
|
766
|
717 |
| Current assets |
687
|
763
|
712 |
| Current liabilities |
91
|
95
|
246 |
| Equity capital |
280
|
374
|
420 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
40.6%
|
48.8%
|
58.6% |
| Turnover per employee |
247
|
225
|
582 |
| Profit as a percentage of turnover |
-20.1%
|
-13.1%
|
8.9% |
| Return on assets (ROA) |
-19.9%
|
-10.6%
|
21.8% |
| Current ratio |
754.9%
|
803.2%
|
289.4% |
| Return on equity (ROE) |
-53.2%
|
-23.5%
|
36.9% |
| Change turnover |
19
|
-1,008
|
69 |
| Change turnover % |
3%
|
-60%
|
4% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.